The Observed Variance Between Predicted and Measured Radiation Dose in Breast and Prostate Patients Utilizing an In Vivo Dosimeter

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 2, 2008, Pages 597-604

  Scarantino, Charles W ^a,d   Prestidge, Bradley R ^c   Anscher, Mitchel S ^b   Ferree, Carolyn R ^e   Kearns, William T ^e   Black, Robert D ^a   Bolick, Natasha G ^a   Beyer, Gloria P ^a  

^a Sicel Technologies   (United States)

^b Rex Cancer Center   (United States)

^c Texas Cancer Clinic   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Dosimetry prostate and breast cancer; Implantable dosimeter; In situ radiation

Indexed keywords

COMPUTER NETWORKS; COMPUTERIZED TOMOGRAPHY; DATA TRANSFER; DIAGNOSTIC RADIOGRAPHY; FIELD EFFECT TRANSISTORS; MEDICAL IMAGING; PATIENT TREATMENT; RADIOTHERAPY; SEMICONDUCTOR MATERIALS; TOMOGRAPHY;

DOSE VERIFICATION; DOSIMETRY PROSTATE AND BREAST CANCER; IMPLANTABLE DOSIMETER; IN SITU RADIATION;

DOSIMETRY;

METAL OXIDE;

ARTICLE; BLEEDING; BREAST CANCER; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DOSIMETER; DOSIMETRY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SEMICONDUCTOR;

BREAST NEOPLASMS; EQUIPMENT DESIGN; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; MALE; MAMMOGRAPHY; MOVEMENT; PILOT PROJECTS; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOMETRY; RADIOTHERAPY DOSAGE;

EID: 51449091243     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.05.058     Document Type: Article

References (36)

1. Byrne T.E. A review of prostate motion with consideration for the treatment of prostate cancer. Med Dosim 30 (2005) 155-161
2. Scarbrough T.J., Golden N.M., Ting J.Y., et al. Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 65 (2006) 378-387
3. Turner S.L., Swindell R., Bowl N., et al. Bladder movement during radiation therapy for bladder cancer: Implications for treatment planning. Int J Radiat Oncol Biol Phys 39 (1997) 355-360
4. Lebesque J.V., Bruce A.M., Kroes A.P.G., et al. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int J Radiat Oncol Biol Phys 33 (1995) 1109-1119
5. Buchali A., Koswig S., Dinges S., et al. Impact of the filling status of the bladder and rectum on their integral dose distribution and the movement of the uterus in the treatment planning of gynecological cancer. Radiother Oncol 52 (1999) 29-34
6. Nederveen A., van der Heide U.A., Dehnad H., et al. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys 53 (2002) 206-214
7. Balter J., Sandler H.M., Lam K., et al. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 31 (1995) 113-118
8. Britton KR,Takai Y., Mitsuya M., et al. Evaluation of inter and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Radiat Med 23 (2005) 14-24
9. Ross C.S., Hussey D.H., Pennington E.C., et al. Analysis of movement of intrathoracic neoplasms using ultrafast computerized tomography. Int J Radiat Oncol Biol Phys 18 (1990) 671-677
10. Weiss P.H., Baker J.M., and Potchen E.J. Assessment of hepatic respiratory excursion. J Nucl Med 13 (1972) 758-759
11. Suramo I., Päivänsalo M., and Myllyla V. Cranio-caudal movements of the liver pancreas and kidneys in respiration. Acta Radiol Diag 25 (1984) 129-131
12. Vigneault E., Pouliot J., Laverdière J., et al. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: A clinical study. Int J Radiat Oncol Biol Phys 37 (1997) 205-212
13. Padhani A., Khoo V.S., Suckling J., et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int J Radiat Oncol Biol Phys 44 (1999) 525-533
14. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 62 (2005) 406-417
15. Scarantino C.W., Rini C.J., Aquino M., et al. Initial clinical results of an in vivo dosimeter during external beam radiation therapy. Int J Radiat Oncol Biol Phys 62 (2005) 606-613
16. Black R.D., Scarantino C.W., Mann G.G., et al. An analysis of an implantable dosimeter system for external beam therapy. Int J Radiat Oncol Biol Phys 63 (2005) 290-300
17. Beddar A.S., Salehpour M., Briere T.M., et al. Preliminary evaluation of implantable MOSFET radiation dosimeters. Phys Med Biol 50 (2005) 141-149
18. Beyer G.P., Mann G., Pursley J., et al. An implantable MOSFET dosimeter for the measurement of radiation dose in tissue during cancer therapy. IEEE J 8 (2008) 38-51
19. Scarantino C.W., Ruslander D.M., Rini C.J., et al. An implantable radiation dosimeter for use in external beam radiation therapy. Med Phys 31 (2004) 2658
20. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
21. Hayne D., Johnson U., D'Souza D., et al. Anorectal irradiation in pelvic radiotherapy: An assessment using in-vivo dosimetry. Clin Oncol (R Coll Radiol) 13 (2001) 126-129
22. Weber D.C., Nouet P., Kurtz J.M., et al. Assessment of target dose delivery in anal cancer using in vivo thermoluminescent dosimetry. Radiother Oncol 59 (2001) 39-43
23. Wertz H., Boda-Heggemann J., Walter C., et al. Image guided in vivo dosimetry for quality assurance of IMRT treatment for prostate cancer. Int J Radiat Oncol Biol Phys 67 (2007) 288-295
24. Kupelian P., Willoughby T., Mahadevan A., et al. Multi-institutional clinical experience with the Calypso system in localization and continuous, real-time monitoring of the prostate gland during external radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1088-1098
25. Litzenberg D.W., Balter J.M., Hadley S.W., et al. Influence of intrafraction motion on margins for prostate radiotherapy. Int J Radiat Oncol Biol Phys 65 (2006) 528-534
26. Langen K.M., Zhang Y., Andrews R.D., et al. Initial experience with megavoltage (MV) CT guidance for daily prostate alignments. Int J Radiat Oncol Biol Phys 62 (2005) 1517-1524
27. Yue N.J., Li X., Beriwal S., et al. The intrafraction motion induced dosimetric impacts in breast 3D radiation treatment: A 4DCT based study. Med Phys 34 (2007) 2789-2800
28. Beyer G.P., Scarantino C.W., Prestidge B.R., et al. Technical evaluation of radiation dose delivered in prostate patients as measured by an implantable MOSFET dosimeter. Int J Radiat Oncol Biol Phys 69 (2007) 925-935
29. Lattanzi J., Mc Neeley S., Pinover W., et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int J Radiat Oncol Biol Phys 43 (1999) 719-723
30. Langen K.M., Pouliot J., Anezinos C., et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 57 (2003) 635-644
31. Shukovsky L.J. Dose, time, volume relationships in squamous cell carcinoma of the supraglottic larynx. Am J Roent Rad Ther Nucl Med 108 (1970) 27-29
32. Stewart J.F., and Jackson A.W. The steepness of the dose response curve for tumor and normal tissue injury. Laryngoscope 85 (1975) 1107-1111
33. Kaplan H.S. Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease. Cancer Res 26 (1966) 1221-1224
34. Hellman S. Improving the therapeutic index in breast cancer treatment. Cancer Res 40 (1980) 4335-4342
35. Hanks G.E., Hanlon A.L., Epstein B., et al. Dose response in prostate cancer with 8-12 years' follow-up. Int J Radiat Oncol Biol Phys 54 (2002) 427-435
36. Eade T.N., Hanlon A.L., Horwitz E.M., et al. What dose of external-beam radiation is high enough for prostate cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 682-689